Anna Berkenblit
Overview
Anna Berkenblit received an average of $2M in total compensation, including $455K in salary, at ImmunoGen from 2017 to 2021.
2021ImmunoGenSenior Vice President and Chief Medical Officer
2020ImmunoGenSenior Vice President and Chief Medical Officer
2019ImmunoGenSenior Vice President and Chief Medical Officer
2018ImmunoGenSenior Vice President and Chief Medical Officer
2017ImmunoGenSenior Vice President and Chief Medical Officer
Source: SEC filings on April 26, 2022, April 28, 2021, and April 28, 2020.
Related executives
We found 18 more executives who work or worked at ImmunoGen.
Mark Enyedy
ImmunoGen
Chief Executive Officer
Kristen Harrington-Smith
ImmunoGen
Senior Vice President and Chief Commercial Officer
Stacy Coen
ImmunoGen
Senior Vice President and Chief Business Officer
Susan Altschuller
ImmunoGen
Chief Financial Officer
Theresa Wingrove
ImmunoGen
Senior Vice President, Regulatory Affairs and Quality
Richard Gregory
ImmunoGen
Chief Scientific Officer
Thomas Ryll
ImmunoGen
Senior Vice President, Technical Operations
Craig Barrows
ImmunoGen